DRI Capital

DRI Capital - Toronto, Ontario, Canada; acquired by Inwest Investments Ltd. for $83.5 million in March 2002; formerly Drug Royalty Corp. Inc.

Related product monographs:

1. B-cell-activating factor Mab, rDNA -- Tech. ; Former inv.
2. G-CSF, rDNA/Amgen -- Tech.
3. G-CSF, rDNA, PEG-/Amgen -- Tech.
4. RSV Mab, rDNA -- Tech.
5. TNF Mab, rDNA/J&J -- Tech.
6. TNF Receptor-IgG Fc, rDNA -- Tech.
7. Smallpox vaccine/MRC-5 -- Tech.
8. Smallpox vaccine/Vero -- Tech.
9. VEGF aptamer, PEG -- Tech.

Location - Toronto Ontario Canada For

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute